Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Other financing activities (2017 - 2022)

Angiodynamics (ANGO) has disclosed Other financing activities for 9 consecutive years, with $45000.0 as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Other financing activities changed N/A year-over-year to $45000.0, compared with a TTM value of $45000.0 through Aug 2023, down 93.63%, and an annual FY2025 reading of $680000.0, changed N/A over the prior year.
  • Other financing activities was $45000.0 for Q4 2022 at Angiodynamics, down from $706000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $741000.0 in Q3 2019 and bottomed at $34000.0 in Q1 2020.
  • Average Other financing activities over 3 years is $381500.0, with a median of $375500.0 recorded in 2022.